Validity of diagnosis code-based claims to identify pulmonary ntm disease in bronchiectasis patients

Research output: Contribution to journalArticlepeer-review

Abstract

Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.

Original languageEnglish (US)
Pages (from-to)882-885
Number of pages4
JournalEmerging infectious diseases
Volume27
Issue number3
DOIs
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Validity of diagnosis code-based claims to identify pulmonary ntm disease in bronchiectasis patients'. Together they form a unique fingerprint.

Cite this